WallStreetZenWallStreetZen

NASDAQ: MAZE
Maze Therapeutics Inc Stock Ownership - Who owns Maze Therapeutics?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Maze Therapeutics Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Harold BernsteinPresident RD CMO2026-03-203,795$49.32
$187.17kSell
Harold BernsteinPresident RD CMO2026-03-2015,000$10.42
$156.30kBuy
Harold BernsteinPresident RD CMO2026-03-205,044$50.02
$252.30kSell
Harold BernsteinPresident RD CMO2026-03-206,161$48.20
$296.98kSell
Harold BernsteinPresident RD CMO2026-03-10348$51.02
$17.75kSell
Harold BernsteinPresident RD CMO2026-03-1029,652$50.45
$1.50MSell
Harold BernsteinPresident RD CMO2026-03-1030,000$10.42
$312.60kBuy
Amy BachrodtSVP Finance2026-03-021,300$44.44
$57.77kSell
Amy BachrodtSVP Finance2026-03-023,700$45.47
$168.24kSell
Amy BachrodtSVP Finance2026-03-025,000$10.42
$52.10kBuy

1 of 7

MAZE insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when MAZE insiders and whales buy or sell their stock.

MAZE Shareholders

What type of owners hold Maze Therapeutics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Third Rock Ventures IV LP10.91%5,424,758$172.13MInsider
Frazier Life Sciences Management LP9.19%4,567,274$144.92MInstitution
Trv GP IV LLC9.00%4,473,958$141.96MInstitution
Deep Track Capital LP8.54%4,246,440$134.74MInstitution
Arch Venture Management LLC8.29%4,120,053$130.73MInstitution
Janus Henderson Group PLC6.32%3,142,587$99.71MInstitution
Blackrock Inc4.60%2,287,155$72.57MInstitution
A16z Capital Management LLC3.42%1,702,225$54.01MInstitution
Vanguard Group Inc3.41%1,697,015$53.85MInstitution
Vr Adviser LLC3.12%1,548,569$49.14MInstitution

1 of 3

MAZE vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
MAZE88.42%11.58%Net SellingNet Buying
HRMY77.07%22.93%Net SellingNet Selling
VCEL91.16%8.84%Net SellingNet Selling
NTLA72.54%27.46%Net BuyingNet Buying
NRIX93.03%6.97%Net SellingNet Selling
View Top Biotech Stocks

Maze Therapeutics Stock Ownership FAQ

Who owns Maze Therapeutics?

Maze Therapeutics (NASDAQ: MAZE) is owned by 97.30% institutional shareholders, 12.74% Maze Therapeutics insiders, and 0.00% retail investors. Third Rock Ventures IV LP is the largest individual Maze Therapeutics shareholder, owning 5.42M shares representing 10.91% of the company. Third Rock Ventures IV LP's Maze Therapeutics shares are currently valued at $172.02M.

If you're new to stock investing, here's how to buy Maze Therapeutics stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.